Hyaluronic acid is one of the most widely used products in aesthetic-oriented medicine, thanks to its hydrating and volumizing properties and its natural results. However, like any medical procedure, hyaluronic acid filler injections involve certain risks that require particular attention from doctors. In 2024, regulations and safety standards around fillers are evolving to ensure safer practices and better patient protection. This article examines in detail these developments, the new guidelines for doctors and the importance of choosing products that comply with international quality standards.
Injections of hyaluronic acid, although minimally invasive, are not without risks. Possible complications include allergic reactions, infections, bruising and, in rare cases, more serious complications such as skin necrosis or vascular embolism. For this reason, regulatory bodies and professional associations in aesthetic-oriented medicine set strict safety standards in order to minimise these risks and ensure patient safety.
In 2024, regulations are becoming even more stringent, reflecting the growing demand for safe practices and high-quality results. Public health authorities, such as the FDA (Food and Drug Administration) in the United States, Swissmedic (the authority regulating medicines and medical devices) in Switzerland and the EMA (European Medicines Agency) in Europe, are introducing new guidelines that impose higher requirements on filler manufacturers and doctors in terms of quality, training and transparency.
The 2024 regulations place emphasis on the quality of the hyaluronic acid used in injectable products. Fillers must now meet strict criteria regarding their composition, purity and safety. The products must be manufactured in facilities certified according to Good Manufacturing Practices (GMP), with rigorous quality control throughout the production process.
In addition, they must undergo comprehensive safety testing, including clinical studies demonstrating their safety and effectiveness. Practitioners must ensure that the products they use are approved by the relevant regulatory authorities, such as the FDA, Swissmedic or the EMA, and that they bear a CE (Conformité Européenne) marking for countries in the European Union.
In 2024, the guidelines for doctors practising aesthetic-oriented medicine have been strengthened to improve the safety of hyaluronic acid injections. These new recommendations cover several aspects of practice, ranging from initial training to injection techniques.
Patient safety begins with adequate training for doctors. In 2024, it is now mandatory for doctors to undergo certified training courses on hyaluronic acid injection techniques. These trainings include not only theoretical modules on facial anatomy and the properties of fillers, but also practical sessions supervised by experts.
Doctors must also comply with continuing education requirements, regularly participating in advanced workshops and trainings on new injection techniques and technologies. This is important to ensure that doctors have the knowledge and skills necessary to perform injections safely.
The new 2024 guidelines introduce standardized practices for hyaluronic acid injections. For example, the use of ultrasound imaging is becoming increasingly common to improve the precision of injections and avoid blood vessels in order to reduce the risk of vascular complications.
Moreover, doctors must follow strict disinfection protocols before and after injections to prevent infections. The use of micro-cannulas rather than needles is also encouraged, as it minimizes skin trauma and reduces the risk of bruising and bleeding. These standardized practices aim to optimize results while ensuring patient safety.
Even with optimal practices, complications can occur. The 2024 guidelines therefore emphasize the importance for doctors to be prepared to manage potential complications. Each practice must have a detailed emergency plan and rapid access to the medications needed to treat complications such as vascular embolism.
Practitioners must also be trained in the use of hyaluronidase, an enzyme that dissolves hyaluronic acid, in order to quickly treat complications such as vascular occlusion. Communication with the patient about potential risks and the management of complications is also an essential part of the new guidelines.
Technological advances play a crucial role in improving the safety of hyaluronic acid injections. In 2024, several technological innovations enable doctors to perform injections that are safer and more precise.
Ultrasound imaging is one of the most important technologies for injection safety. By allowing practitioners to see subcutaneous structures in real time, this technology helps avoid blood vessels and inject hyaluronic acid in the correct location, thus minimizing the risk of serious complications. Moreover, it allows post-injection assessment to verify proper product distribution and detect any irregularities.
Automated injection devices, such as injector pens, offer increased precision and even distribution of the product. These tools allow exact control over the amount of hyaluronic acid injected at each point, reducing the risk of over- or under-injection. They are particularly useful for treating delicate facial areas, such as the lips or eye contour, where millimetric precision is essential. These devices are especially useful for doctors who are not yet highly experienced.
Artificial intelligence (AI) and big data are also transforming the field of aesthetic-oriented medicine in 2024. AI software can analyse a patient’s facial characteristics and predict the results of a hyaluronic acid injection, thus helping practitioners plan personalised treatments and anticipate possible reactions. These tools also make it possible to monitor trends in complications, thereby contributing to the continuous improvement of safety protocols.
Patients are becoming increasingly aware of the potential risks associated with hyaluronic acid injections and are seeking practitioners who adopt exemplary safety practices. They now expect complete transparency regarding the products used, the practitioner’s qualifications and the procedures in place to manage any potential complications.
The new guidelines also emphasize the importance of communication with the patient. Doctors must clearly explain the benefits and potential risks of hyaluronic acid injections and obtain informed consent before any procedure. They must also be available to answer patients’ questions and concerns at every stage of the process.
Post-treatment follow-up is also crucial to ensure patient safety and satisfaction. Doctors must provide careful follow-up after injections to detect any complications early and intervene if necessary. Post-treatment monitoring helps build patient trust and ensures optimal results.
In 2024, the safety of hyaluronic acid injections relies on a combination of strict regulations, advanced technologies and exemplary practices from doctors. The adoption of new standards and guidelines, the integration of innovative technologies such as ultrasound imaging and automated injection devices are important to minimise risks and maximise patient satisfaction.
For patients, choosing a well-trained, experienced doctor who is transparent about their practices is a guarantee of a safe and satisfactory procedure.
Article written by Dr Romano Valeria
SHARE THIS ARTICLE ON
